Report copyright - Targeting the Leukemia Antigen PR1 with Immunotherapy for ... · PR1 peptide vaccine, anti-PR1/HLA-A2 antibody, and PR1-specific T-cell therapies. Furthermore, in addition to its
Please pass captcha verification before submit form
Please pass captcha verification before submit form